- Home
- THCH vs VRCA Comparison
THCH vs VRCA Comparison
Compare THCH & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- VRCA
- Stock Information
- Founded
- THCH 2018
- VRCA 2013
- Country
- THCH China
- VRCA United States
- Employees
- THCH N/A
- VRCA N/A
- Industry
- THCH Blank Checks
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- THCH Finance
- VRCA Health Care
- Exchange
- THCH Nasdaq
- VRCA Nasdaq
- Market Cap
- THCH 84.8M
- VRCA 80.7M
- IPO Year
- THCH N/A
- VRCA 2018
- Fundamental
- Price
- THCH $2.94
- VRCA $6.61
- Analyst Decision
- THCH
- VRCA Hold
- Analyst Count
- THCH 0
- VRCA 5
- Target Price
- THCH N/A
- VRCA $6.00
- AVG Volume (30 Days)
- THCH 7.8K
- VRCA 89.8K
- Earning Date
- THCH 08-28-2025
- VRCA 08-13-2025
- Dividend Yield
- THCH N/A
- VRCA N/A
- EPS Growth
- THCH N/A
- VRCA N/A
- EPS
- THCH N/A
- VRCA N/A
- Revenue
- THCH $187,384,526.00
- VRCA $7,179,000.00
- Revenue This Year
- THCH N/A
- VRCA $165.25
- Revenue Next Year
- THCH N/A
- VRCA $80.06
- P/E Ratio
- THCH N/A
- VRCA N/A
- Revenue Growth
- THCH N/A
- VRCA N/A
- 52 Week Low
- THCH $2.15
- VRCA $3.82
- 52 Week High
- THCH $5.15
- VRCA $73.70
- Technical
- Relative Strength Index (RSI)
- THCH 54.80
- VRCA 43.98
- Support Level
- THCH $2.84
- VRCA $6.70
- Resistance Level
- THCH $2.95
- VRCA $7.50
- Average True Range (ATR)
- THCH 0.09
- VRCA 1.00
- MACD
- THCH -0.01
- VRCA -0.21
- Stochastic Oscillator
- THCH 54.84
- VRCA 20.60
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.